SCHEMBL7793582

SCHEMBL7793582

CCOP(=O)(OCC)C(Nc1ccncc1)P(=O)(OCC)OCC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
EPHX2 P34913 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
GAA P10253 1/20 0.40
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA2 P00918 4/20 0.39
CA9 Q16790 4/20 0.39
POLB P06746 1/20 0.39
FDPS P14324 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8167824 0.84 FDPS (0.44) KDM4EEPHX2MEN1KMT2ALMNA
SCHEMBL5366533 0.81 FDPS (0.59) LMNAPOLBFDPSNPSR1MAPT
SCHEMBL9274896 0.75 L3MBTL1 (0.38) L3MBTL1GAACA12CA1CA2
SCHEMBL21501951 0.74 FDPS (0.39) KDM4EEPHX2L3MBTL1LMNAPTPN2
SCHEMBL7793634 0.74 FDFT1 (0.42) KDM4EEPHX2L3MBTL1LMNAPTPN2
SCHEMBL7793613 0.74 L3MBTL1 (0.45) KDM4EMEN1KMT2AL3MBTL1LMNA
SCHEMBL5359859 0.73 TSHR (0.42) KDM4EMEN1KMT2AGAAPOLB
SCHEMBL5360999 0.73 FDPS (0.58) KDM4EMEN1KMT2AL3MBTL1GAA
SCHEMBL7784734 0.73 KMT2A (0.45) KDM4EMEN1KMT2ALMNAGAA
SCHEMBL9602498 0.72 KDM4E (0.46) KDM4EEPHX2MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0762883-B1 PYRIDYLBISPHOSPHONATES FOR USE AS A THERAPEUTICAL AGENT LEIRAS OY (FI) 2001-11-14 EP claimed
EP-0762883-A1 PYRIDYLBISPHOSPHONATES FOR USE AS A THERAPEUTICAL AGENT LEIRAS OY (FI) 1997-03-19 EP claimed
WO-1995033466-A1 PYRIDYLBISPHOSPHONATES FOR USE AS A THERAPEUTICAL AGENT LEIRAS OY (FI) 1995-12-14 WO claimed
EP-0762883-B1 PYRIDYLBISPHOSPHONATES FOR USE AS A THERAPEUTICAL AGENT LEIRAS OY (FI) 2001-11-14 EP disclosed
US-5866556-A BONE DISORDERS LEIRAS OY (FI) 1999-02-02 US disclosed
US-5393748-A Treating bone disorders, Paget* s disease, calcium metabolism disorders LEIRAS OY (FI) 1995-02-28 US disclosed